Digitoxin ( DrugBank: Digitoxin )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 299 | Cystic fibrosis | 1 |
299. Cystic fibrosis
Clinical trials : 1,696 / Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00782288 (ClinicalTrials.gov) | August 2010 | 29/10/2008 | Phase II Study of Digitoxin to Treat Cystic Fibrosis | Phase II Study of Digitoxin to Treat Cystic Fibrosis | Cystic Fibrosis | Drug: digitoxin;Other: placebo | National Jewish Health | NULL | Completed | 18 Years | 45 Years | All | 24 | Phase 2 | United States |